The efficacy of rivaroxaban when compared with warfarin for the prevention of stroke or systemic embolism was similar in patients with PAD ( HR : 1.19 , 95 % CI : 0.63-2 .22 ) and without PAD ( HR : 0.86 , 95 % CI : 0.73-1 .02 ; interaction P = 0.34 ) .